Patients with liver cirrhosis, Hepatocellular Carcinoma or other malignancies.
Patients with other factors causing liver diseases.
Pregnant and lactating women.
Patients with concomitant HIV infection or congenital immune deficiency diseases.
Patients with diabetes, autoimmune diseases.
Patients with important organ dysfunctions.
Patients with serious complications (e.g., infection, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding.)
Patients who receive antineoplastic or immunomodulatory therapy in the past 12 months.
Patients who can't come back to clinic for follow-up on schedule.

NCT02745704_exc_T1
Condition
liver cirrhosis
NCT02745704_exc_T2
Condition
Hepatocellular Carcinoma
NCT02745704_exc_T3
Condition
malignancies
NCT02745704_exc_T6
Condition
HIV infection
NCT02745704_exc_T7
Qualifier
concomitant
NCT02745704_exc_T8
Condition
congenital immune deficiency diseases.
NCT02745704_exc_T9
Condition
diabetes
NCT02745704_exc_T10
Condition
autoimmune diseases
NCT02745704_exc_T11
Condition
organ dysfunctions
NCT02745704_exc_T12
Qualifier
serious
NCT02745704_exc_T13
Condition
complications
NCT02745704_exc_T14
Condition
infection
NCT02745704_exc_T15
Condition
hepatic encephalopathy
NCT02745704_exc_T16
Condition
hepatorenal syndrome
NCT02745704_exc_T17
Condition
gastrointestinal bleeding
NCT02745704_exc_T18
Scope
infection, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding
NCT02745704_exc_T19
Procedure
plastic or imm  in th
NCT02745704_exc_T20
Procedure
immunomodulatory therapy
NCT02745704_exc_T21
Temporal
past 12 months
NCT02745704_exc_T22
Scope
antineoplastic or immunomodulatory therapy